000 01519 a2200421 4500
005 20250517011752.0
264 0 _c20160119
008 201601s 0 0 eng d
022 _a1573-0646
024 7 _a10.1007/s10637-014-0203-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTrendowski, Matthew
245 0 0 _aChemotherapy with cytochalasin congeners in vitro and in vivo against murine models.
_h[electronic resource]
260 _bInvestigational new drugs
_cApr 2015
300 _a290-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aCytochalasin B
_xadministration & dosage
650 0 4 _aCytochalasin D
_xadministration & dosage
650 0 4 _aCytochalasins
_xadministration & dosage
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aDrug Synergism
650 0 4 _aLeukemia P388
_xdrug therapy
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMelanoma
_xdrug therapy
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aTumor Cells, Cultured
700 1 _aMitchell, Joan M
700 1 _aCorsette, Christine M
700 1 _aAcquafondata, Christopher
700 1 _aFondy, Thomas P
773 0 _tInvestigational new drugs
_gvol. 33
_gno. 2
_gp. 290-9
856 4 0 _uhttps://doi.org/10.1007/s10637-014-0203-5
_zAvailable from publisher's website
999 _c24510476
_d24510476